Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the national surgical adjuvant breast and bowel project B-16

Journal of Clinical Oncology

Volumn 8, Issue 6, 1990, Pages 1005-1018

  Fisher, Bernard ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MELPHALAN; TAMOXIFEN;

ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CONTROLLED STUDY; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOPHLEBITIS; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; FLUOROURACIL; HUMAN; LYMPHATIC METASTASIS; MELPHALAN; MIDDLE AGE; MULTICENTER STUDIES; NEOPLASMS, HORMONE-DEPENDENT; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN;

EID: 0025334752     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1990.8.6.1005     Document Type: Article

References (4)

1. Nolvadex Adjuvant Trial Organization: Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1:836-839,1985
2. The Scottish Trial: Adjuvant tamoxifen in the management of operable breast cancer. Lancet 2:171-175, 1987
3. Early Breast Cancer Trialists' Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 319:1681-1692,1988
4. Goldhirsch A, Gelber R: Adjuvant treatment for early breast cancer: The Ludwig breast cancer studies. NCI Monogr 1:55-70,1986